Medical Science Liaison - FL/Puerto Rico (Tampa based)

Advanced Degree Required (PhD, PharmD, or MD)

Experience in the pharmaceutical industry, including 3+ years in a field medical/MSL role

Broad knowledge of general medicine with a focus in hematology, oncology or interferons.

Knowledge in planning and execution of scientific studies and clinical trials

Ability to develop and maintain relationships with key thought-leaders.

Ability to introduce the disease state to the KOL community and articulate complex programs.

PharmaEssentia USA strives every day to improve the lives of patients as well as our employees. As a valued member of PharmaEssentia USA, you will enjoy the following benefits:

Comprehensive medical coverage

Dental and vision coverage

Generous paid time-off

401(k) retirement plan with competitive company match

Medical & Dependent Care Flexible Spending Account

The primary responsibility of a Medical Science Liaison (MSL) is the exchange of medical information with health care professionals (HCPs) involved with the management of myeloproliferative neoplasms (MPNs). As a key member of the Medical Affairs Team, you will facilitate and develop the relationship with the medical/scientific community including physicians and medical centers, by communicating product-related information to investigators and institutions. In addition, you will provide information on research developments, new clinical trials and new concepts in medical treatment, to bring our flagship product to market for the treatment of polycythemia vera (PV).

Hired candidate must reside in Florida, with strong preference for Tampa.

:

Establish a respectable PharmaEssentia presence in the medical community.

Identify and develop relationships with the medical community, thought leaders, and treatment advocates.

It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity at PharmaEssentia. Join us, and let’s transform lives, together.

PharmaEssentia Corporation is a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved and a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking. Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taiwan Stock Exchange (TWSE: 6446) and are expanding our global presence with operations in the U.S., Japan, Singapore, South Korea, and China, along with a world-class biologics production facility in Taichung.